Cargando…
Targeting the YAP/TAZ Pathway in Uveal and Conjunctival Melanoma With Verteporfin
PURPOSE: The purpose of this study was to determine whether YAP/TAZ activation in uveal melanoma (UM) and the susceptibility of melanoma cell lines to YAP/TAZ inhibition by verteporfin (VP) is related to the tumor's genetic background. METHODS: Characteristics of 144 patients with enucleated UM...
Autores principales: | Brouwer, Niels J., Konstantinou, Eleni K., Gragoudas, Evangelos S., Marinkovic, Marina, Luyten, Gregorius P. M., Kim, Ivana K., Jager, Martine J., Vavvas, Demetrios G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Association for Research in Vision and Ophthalmology
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8024781/ https://www.ncbi.nlm.nih.gov/pubmed/33798262 http://dx.doi.org/10.1167/iovs.62.4.3 |
Ejemplares similares
-
Prognostic Factors Five Years After Enucleation for Uveal Melanoma
por: Dogrusöz, Mehmet, et al.
Publicado: (2020) -
Preclinical Evaluation of Trabectedin in Combination With Targeted Inhibitors for Treatment of Metastatic Uveal Melanoma
por: Glinkina, Kseniya, et al.
Publicado: (2022) -
In Vitro Testing of the Virus-Like Drug Conjugate Belzupacap Sarotalocan (AU-011) on Uveal Melanoma Suggests BAP1-Related Immunostimulatory Capacity
por: Ma, Sen, et al.
Publicado: (2023) -
BRAF, NRAS, and GNAQ Mutations in Conjunctival Melanocytic Nevi
por: Francis, Jasmine H., et al.
Publicado: (2018) -
Verteporfin inhibits growth of human glioma in vitro without light activation
por: Al-Moujahed, Ahmad, et al.
Publicado: (2017)